MA29097B1 - Composes pour le traitement des infections virales par flaviviridae - Google Patents

Composes pour le traitement des infections virales par flaviviridae

Info

Publication number
MA29097B1
MA29097B1 MA29999A MA29999A MA29097B1 MA 29097 B1 MA29097 B1 MA 29097B1 MA 29999 A MA29999 A MA 29999A MA 29999 A MA29999 A MA 29999A MA 29097 B1 MA29097 B1 MA 29097B1
Authority
MA
Morocco
Prior art keywords
flaviviridae
compounds
treatment
viral infections
infections
Prior art date
Application number
MA29999A
Other languages
English (en)
Inventor
Beat Weidmann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29097B1 publication Critical patent/MA29097B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA29999A 2004-12-23 2007-06-18 Composes pour le traitement des infections virales par flaviviridae MA29097B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63867604P 2004-12-23 2004-12-23

Publications (1)

Publication Number Publication Date
MA29097B1 true MA29097B1 (fr) 2007-12-03

Family

ID=36218613

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29999A MA29097B1 (fr) 2004-12-23 2007-06-18 Composes pour le traitement des infections virales par flaviviridae

Country Status (17)

Country Link
US (1) US20090214464A1 (fr)
EP (1) EP1830870A1 (fr)
JP (1) JP2008525458A (fr)
KR (1) KR20070089954A (fr)
CN (1) CN101084005A (fr)
AU (1) AU2005322241B2 (fr)
BR (1) BRPI0519355A2 (fr)
CA (1) CA2587586A1 (fr)
IL (1) IL183780A0 (fr)
MA (1) MA29097B1 (fr)
MX (1) MX2007007721A (fr)
NO (1) NO20073765L (fr)
NZ (1) NZ555142A (fr)
RU (1) RU2007128098A (fr)
TN (1) TNSN07240A1 (fr)
WO (1) WO2006071618A1 (fr)
ZA (1) ZA200703907B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
EP1931696B1 (fr) 2005-09-30 2011-02-16 Scynexis, Inc. Derives d'arylalkyle et d'heteroarylalkyle de cyclosporine a utilises pour traiter et prevenir une infection virale
KR20080059270A (ko) 2005-09-30 2008-06-26 싸이넥시스, 인크. Ｃ형 간염 감염의 치료 및 예방을 위한 방법 및 제약조성물
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
DE602007013391D1 (de) 2006-05-19 2011-05-05 Scynexis Inc Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
WO2008069917A2 (fr) 2006-11-20 2008-06-12 Scynexis, Inc. Nouveaux peptides cycliques
CN102083852A (zh) 2008-06-06 2011-06-01 西尼克斯公司 环孢菌素类似物及其在治疗hcv感染中的应用
CA2748389A1 (fr) 2008-12-31 2010-07-08 Scynexis, Inc. Derives de cyclosporine a
WO2011063076A1 (fr) 2009-11-19 2011-05-26 Itherx Pharmaceuticals, Inc. Méthodes de traitement du virus de l'hépatite c avec des composés d'oxo-acétamide
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0484281T4 (da) * 1990-11-02 2001-02-05 Novartis Ag Cyclosporiner
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
WO2002032447A2 (fr) * 2000-10-19 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Inhibiteur de degat cellulaire
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
ES2357587T3 (es) * 2004-10-01 2011-04-27 Debiopharm S.A. Uso de (d-meala)3-(etval)4-ciclosporina para el tratamiento de infección por hepatitis c.
WO2006071619A1 (fr) * 2004-12-23 2006-07-06 Novartis Ag Compositions pour le traitement du vhc

Also Published As

Publication number Publication date
NZ555142A (en) 2010-03-26
CA2587586A1 (fr) 2006-07-06
US20090214464A1 (en) 2009-08-27
BRPI0519355A2 (pt) 2009-01-20
CN101084005A (zh) 2007-12-05
JP2008525458A (ja) 2008-07-17
IL183780A0 (en) 2007-09-20
KR20070089954A (ko) 2007-09-04
TNSN07240A1 (en) 2008-11-21
AU2005322241A1 (en) 2006-07-06
MX2007007721A (es) 2007-08-14
NO20073765L (no) 2007-09-19
AU2005322241B2 (en) 2010-02-18
EP1830870A1 (fr) 2007-09-12
RU2007128098A (ru) 2009-01-27
ZA200703907B (en) 2009-08-26
WO2006071618A1 (fr) 2006-07-06

Similar Documents

Publication Publication Date Title
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
HK1221956A1 (zh) 用於治療感染的鹵代類苯酞化硼
MA29098B1 (fr) Compositions pour le traitement du vhc
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
IL187999A0 (en) Compositions for the treatment of persistent infections
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL184955A0 (en) Tricyclic-nucleoside compounds for treating viral infections
SI2193131T1 (sl) Imidazo(1,2-A)pirazin spojine za zdravljenje virusnih okuĹľb kot je hepatitis
EP1865967A4 (fr) Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
SI1951272T1 (sl) Uporaba lactobacillus za zdravljenje virusnih infekcij
EP1817024A4 (fr) Derives d'andrographolide servant a traiter les infections virales
PL376409A1 (en) Composition for the treatment of infection by flaviviridae viruses
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
DK1812002T3 (da) Behandling af mastitis
DK2069353T3 (da) Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus
EP1626692A4 (fr) Composes permettant de traiter les infections par flavivirus
FR2889518B1 (fr) Systeme pour le traitement des eaux usees domestiques
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.